Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 11:10 am Sale | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | The Vanguard Group | 15,892,347 9.930% | -746,594 (-4.49%) | Filing History |
| 2021-02-04 09:45 am Sale | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | Wellington Management Group LLP | 21,653,549 13.530% | -124,152 (-0.57%) | Filing History |
| 2021-01-29 5:23 pm Sale | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | BlackRock Inc. BLK | 13,044,650 8.100% | -496,895 (-3.67%) | Filing History |
| 2021-01-06 7:25 pm Purchase | 2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | WESTFIELD CAPITAL MANAGEMENT CO LP | 8,488,042 5.300% | 8,488,042 (New Position) | Filing History |
| 2020-11-10 10:27 am Sale | 2020-11-09 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | FMR LLC | 2,807,589 1.748% | -8,545,905 (-75.27%) | Filing History |
| 2020-11-09 09:59 am Sale | 2020-11-05 | 13D | Ironwood Pharmaceuticals, Inc. IRWD | Sarissa Capital Management LP | 0 0.000% | -12,493,000 (Position Closed) | Filing History |